Estimating Waning of Vaccine Effectiveness: a Simulation Study
Ariel Nikas, Hasan Ahmed, and Veronika I. Zarnitsyna

TL;DR
This study evaluates statistical methods for estimating vaccine effectiveness waning over time, highlighting the limitations of existing models and proposing an improved Cox model extension with time-vaccine interaction for better accuracy.
Contribution
The paper introduces an optimized Cox proportional hazards model with a time-vaccine interaction term to more accurately estimate rapid intra-seasonal vaccine effectiveness waning.
Findings
Partitioning time and including interaction terms improves VE waning estimates.
Scaled Schoenfeld residuals are unreliable for capturing rapid waning.
Optimized partitioning scheme enhances model performance.
Abstract
Developing accurate and reliable methods to estimate vaccine protection is a key goal in immunology and public health. While several statistical methods have been proposed, their potential inaccuracy in capturing fast intra-seasonal waning of vaccine-induced protection needs to be rigorously investigated. To compare statistical methods for vaccine effectiveness (VE) estimation, we generated simulated data using a multiscale agent-based model of an epidemic with an acute viral infection and differing extents of VE waning. We extended the previously proposed framework for VE measures based on the observational data richness to assess changes of vaccine-induced protection with time. While VE measures based on hard-to-collect information (e.g. exact timing of exposures) were accurate, usually VE studies rely on time-to-infection data and the Cox proportional hazard model. We found that its…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Influenza Virus Research Studies · vaccines and immunoinformatics approaches
